使用女性干预疗效指数（FIEI）作为治疗女性性功能障碍的医学干预的直接结局指标。

The use of the Female Intervention Efficacy Index (FIEI) as an immediate outcome measure of medical intervention to treat female sexual dysfunction.

作者信息

Berman L A, Berman J R, Werbin T, Chabra S, Goldstein I

机构信息

Division of Urology, UCLA Medical Center, 924 Westwood Ave., #520, Los Angeles, CA 90024, USA.

出版信息

J Sex Marital Ther. 2001 Oct-Dec;27(5):427-33. doi: 10.1080/713846821.

DOI:10.1080/713846821

PMID:11554203

Abstract

Many medications used in the treatment of male erectile dysfunction are still in the experimental phases for use in women. Numerous pharmacological options for women presently under testing include the EROS-CTD clitoral therapy device (Berman et al., 1999b; Billups et al., 2001). In addition to the new medical developments for treating female sexual dysfunction, methods for evaluating sexual responses and efficacy of intervention are evolving as well.

摘要

许多用于治疗男性勃起功能障碍的药物仍处于针对女性的试验阶段。目前正在测试的针对女性的众多药理学选择包括爱若思阴蒂治疗装置（伯曼等人，1999年b；比卢普斯等人，2001年）。除了治疗女性性功能障碍的新医学进展外，评估性反应和干预效果的方法也在不断发展。